| UniProt ID | SYSC_HUMAN | |
|---|---|---|
| UniProt AC | P49591 | |
| Protein Name | Serine--tRNA ligase, cytoplasmic | |
| Gene Name | SARS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 514 | |
| Subcellular Localization | Cytoplasm . Nucleus . Predominantly cytoplasmic, but a minor proportion is also found in the nucleus. | |
| Protein Description | Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser). [PubMed: 22353712] | |
| Protein Sequence | MVLDLDLFRVDKGGDPALIRETQEKRFKDPGLVDQLVKADSEWRRCRFRADNLNKLKNLCSKTIGEKMKKKEPVGDDESVPENVLSFDDLTADALANLKVSQIKKVRLLIDEAILKCDAERIKLEAERFENLREIGNLLHPSVPISNDEDVDNKVERIWGDCTVRKKYSHVDLVVMVDGFEGEKGAVVAGSRGYFLKGVLVFLEQALIQYALRTLGSRGYIPIYTPFFMRKEVMQEVAQLSQFDEELYKVIGKGSEKSDDNSYDEKYLIATSEQPIAALHRDEWLRPEDLPIKYAGLSTCFRQEVGSHGRDTRGIFRVHQFEKIEQFVYSSPHDNKSWEMFEEMITTAEEFYQSLGIPYHIVNIVSGSLNHAASKKLDLEAWFPGSGAFRELVSCSNCTDYQARRLRIRYGQTKKMMDKVEFVHMLNATMCATTRTICAILENYQTEKGITVPEKLKEFMPPGLQELIPFVKPAPIEQEPSKKQKKQHEGSKKKAAARDVTLENRLQNMEVTDA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MVLDLDLF -------CCEECEEE | 6.44 | 19413330 | |
| 12 | Ubiquitination | LDLFRVDKGGDPALI CEEEEECCCCCHHHH | 63.03 | - | |
| 12 | Acetylation | LDLFRVDKGGDPALI CEEEEECCCCCHHHH | 63.03 | 25953088 | |
| 12 | Malonylation | LDLFRVDKGGDPALI CEEEEECCCCCHHHH | 63.03 | 26320211 | |
| 22 | Phosphorylation | DPALIRETQEKRFKD CHHHHHHHHHHHHCC | 31.98 | 30576142 | |
| 25 | Ubiquitination | LIRETQEKRFKDPGL HHHHHHHHHHCCCCH | 54.00 | - | |
| 28 | 2-Hydroxyisobutyrylation | ETQEKRFKDPGLVDQ HHHHHHHCCCCHHHH | 68.02 | - | |
| 28 | Ubiquitination | ETQEKRFKDPGLVDQ HHHHHHHCCCCHHHH | 68.02 | - | |
| 38 | Ubiquitination | GLVDQLVKADSEWRR CHHHHHHHCCHHHHH | 55.88 | 21906983 | |
| 55 | Acetylation | FRADNLNKLKNLCSK HHHHCHHHHHHHHHH | 65.09 | 25953088 | |
| 55 | Ubiquitination | FRADNLNKLKNLCSK HHHHCHHHHHHHHHH | 65.09 | - | |
| 57 | Ubiquitination | ADNLNKLKNLCSKTI HHCHHHHHHHHHHHH | 49.86 | - | |
| 62 | Acetylation | KLKNLCSKTIGEKMK HHHHHHHHHHHHHHC | 43.07 | 25953088 | |
| 62 | Malonylation | KLKNLCSKTIGEKMK HHHHHHHHHHHHHHC | 43.07 | 26320211 | |
| 62 | Ubiquitination | KLKNLCSKTIGEKMK HHHHHHHHHHHHHHC | 43.07 | - | |
| 63 | Phosphorylation | LKNLCSKTIGEKMKK HHHHHHHHHHHHHCC | 20.23 | 21949786 | |
| 67 | Ubiquitination | CSKTIGEKMKKKEPV HHHHHHHHHCCCCCC | 51.29 | - | |
| 70 | Ubiquitination | TIGEKMKKKEPVGDD HHHHHHCCCCCCCCC | 59.89 | - | |
| 71 | Ubiquitination | IGEKMKKKEPVGDDE HHHHHCCCCCCCCCC | 62.83 | - | |
| 79 | Phosphorylation | EPVGDDESVPENVLS CCCCCCCCCCCCCCC | 50.39 | 26434776 | |
| 99 | Ubiquitination | ADALANLKVSQIKKV HHHHHCCCHHHHHHH | 39.38 | - | |
| 101 | Phosphorylation | ALANLKVSQIKKVRL HHHCCCHHHHHHHHH | 25.30 | - | |
| 116 | Ubiquitination | LIDEAILKCDAERIK HHCHHHHHCCHHHHH | 24.77 | - | |
| 116 | 2-Hydroxyisobutyrylation | LIDEAILKCDAERIK HHCHHHHHCCHHHHH | 24.77 | - | |
| 117 | Glutathionylation | IDEAILKCDAERIKL HCHHHHHCCHHHHHH | 5.55 | 22555962 | |
| 123 | Ubiquitination | KCDAERIKLEAERFE HCCHHHHHHHHHHHH | 46.63 | - | |
| 123 | 2-Hydroxyisobutyrylation | KCDAERIKLEAERFE HCCHHHHHHHHHHHH | 46.63 | - | |
| 123 | Acetylation | KCDAERIKLEAERFE HCCHHHHHHHHHHHH | 46.63 | 25953088 | |
| 142 | Phosphorylation | IGNLLHPSVPISNDE HHHHHCCCCCCCCCC | 29.76 | 22617229 | |
| 154 | Acetylation | NDEDVDNKVERIWGD CCCCHHHHHHHHHHC | 40.80 | 26051181 | |
| 154 | Ubiquitination | NDEDVDNKVERIWGD CCCCHHHHHHHHHHC | 40.80 | 21890473 | |
| 157 | Methylation | DVDNKVERIWGDCTV CHHHHHHHHHHCCHH | 32.71 | 115493327 | |
| 167 | Acetylation | GDCTVRKKYSHVDLV HCCHHHHCCCCCCEE | 41.23 | 7823055 | |
| 184 | Acetylation | VDGFEGEKGAVVAGS ECCCCCCCCEEEEEC | 64.13 | 7823063 | |
| 191 | Phosphorylation | KGAVVAGSRGYFLKG CCEEEEECCCHHHHH | 16.88 | 23898821 | |
| 231 | Ubiquitination | YTPFFMRKEVMQEVA CCCHHHHHHHHHHHH | 42.76 | - | |
| 234 | Sulfoxidation | FFMRKEVMQEVAQLS HHHHHHHHHHHHHHH | 2.70 | 30846556 | |
| 241 | Phosphorylation | MQEVAQLSQFDEELY HHHHHHHHHCCHHHH | 19.40 | 17525332 | |
| 248 | Phosphorylation | SQFDEELYKVIGKGS HHCCHHHHHHHCCCC | 13.39 | - | |
| 249 | Ubiquitination | QFDEELYKVIGKGSE HCCHHHHHHHCCCCC | 39.75 | - | |
| 253 | Ubiquitination | ELYKVIGKGSEKSDD HHHHHHCCCCCCCCC | 48.41 | - | |
| 255 | Phosphorylation | YKVIGKGSEKSDDNS HHHHCCCCCCCCCCC | 45.39 | - | |
| 257 | Ubiquitination | VIGKGSEKSDDNSYD HHCCCCCCCCCCCCC | 61.96 | 21890473 | |
| 258 | Phosphorylation | IGKGSEKSDDNSYDE HCCCCCCCCCCCCCC | 46.26 | 28985074 | |
| 262 | Phosphorylation | SEKSDDNSYDEKYLI CCCCCCCCCCCCEEE | 40.74 | - | |
| 266 | Acetylation | DDNSYDEKYLIATSE CCCCCCCCEEEEECC | 42.32 | 27452117 | |
| 266 | Ubiquitination | DDNSYDEKYLIATSE CCCCCCCCEEEEECC | 42.32 | 21890473 | |
| 293 | Ubiquitination | RPEDLPIKYAGLSTC CCCCCCCCCCCHHHH | 27.40 | - | |
| 317 | Methylation | RDTRGIFRVHQFEKI CCCCCEEEEEECCEE | 24.08 | 115493319 | |
| 323 | Acetylation | FRVHQFEKIEQFVYS EEEEECCEEEHHHHC | 53.48 | 19608861 | |
| 323 | Ubiquitination | FRVHQFEKIEQFVYS EEEEECCEEEHHHHC | 53.48 | 19608861 | |
| 329 | Phosphorylation | EKIEQFVYSSPHDNK CEEEHHHHCCCCCCC | 12.52 | 28152594 | |
| 330 | Phosphorylation | KIEQFVYSSPHDNKS EEEHHHHCCCCCCCC | 31.90 | 28152594 | |
| 331 | Phosphorylation | IEQFVYSSPHDNKSW EEHHHHCCCCCCCCH | 14.47 | 25627689 | |
| 368 | Phosphorylation | IVNIVSGSLNHAASK HHHHHHCCCCHHHHC | 20.63 | - | |
| 376 | Ubiquitination | LNHAASKKLDLEAWF CCHHHHCCCCHHHHC | 44.75 | 21890473 | |
| 396 | Phosphorylation | FRELVSCSNCTDYQA HHHHHCCCCCCHHHH | 27.68 | 28152594 | |
| 399 | Phosphorylation | LVSCSNCTDYQARRL HHCCCCCCHHHHHHH | 41.83 | 28152594 | |
| 401 | Phosphorylation | SCSNCTDYQARRLRI CCCCCCHHHHHHHHH | 5.97 | 28152594 | |
| 438 | Glutathionylation | CATTRTICAILENYQ HHHHHHHHHHHHHHC | 1.58 | 22555962 | |
| 444 | Phosphorylation | ICAILENYQTEKGIT HHHHHHHHCCCCCCC | 13.87 | 22210691 | |
| 446 | Phosphorylation | AILENYQTEKGITVP HHHHHHCCCCCCCCC | 29.33 | 22210691 | |
| 448 | Ubiquitination | LENYQTEKGITVPEK HHHHCCCCCCCCCHH | 60.03 | - | |
| 451 | Phosphorylation | YQTEKGITVPEKLKE HCCCCCCCCCHHHHH | 38.38 | 22210691 | |
| 455 | Ubiquitination | KGITVPEKLKEFMPP CCCCCCHHHHHHCCC | 59.81 | - | |
| 472 | Ubiquitination | QELIPFVKPAPIEQE HHHCCCCCCCCCCCC | 35.52 | - | |
| 481 | Phosphorylation | APIEQEPSKKQKKQH CCCCCCCCHHHHHCC | 52.30 | 26434776 | |
| 491 | Phosphorylation | QKKQHEGSKKKAAAR HHHCCCCHHHHHHHH | 38.01 | 26074081 | |
| 501 | Phosphorylation | KAAARDVTLENRLQN HHHHHHCCHHHHHHH | 32.42 | 29255136 | |
| 505 | Methylation | RDVTLENRLQNMEVT HHCCHHHHHHHCCCC | 28.42 | 115493311 | |
| 512 | Phosphorylation | RLQNMEVTDA----- HHHHCCCCCC----- | 16.95 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYSC_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYSC_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYSC_HUMAN !! | ||||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00133 | L-Serine |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-323, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |